EMA's committee says expanded label for Lilly's Mounjaro into sleep apnea not necessary

The European Medicines Agency’s human medicines committee (CHMP) handed down 17 recommendations for drug approvals on Friday but said a label expansion of Eli Lilly's blockbuster diabetes drug Mounjaro into obstructive sleep apnea isn’t necessary ...